Article

PHARMACOGENOMICS OF NOVEL ORAL ANTICOAGULANTS (NOACs): CURRENT INSIGHTS AND FUTURE DIRECTIONS

2024-12-19

Abstract excerpt

Novel oral anticoagulants (NOACs) have revolutionized anticoagulation therapy by surpassing the limitations of warfarin and providing broader therapeutic effect, fewer drug-food and drug-drug interactions, and elimination of routine coagulation monitoring. However, inter-individual variabilities in drug responses have resulted in recurrent thromboembolic events and bleeding complications. Genetic variations that a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d7c59156-03db-5683-b16b-f5f27d38e533
DOI: 10.22541/au.173460442.25379124/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

PHARMACOGENOMICS OF NOVEL ORAL ANTICOAGULANTS (NOACs): CURRENT INSIGHTS AND FUTURE DIRECTIONSDOI 10.22541/au.173460442.25379124/v1Read

Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic VariantsSemantic proximity Read

Pharmacogenetics of Novel Oral Anticoagulants: A Review of Identified Gene Variants & Future PerspectivesSemantic proximity Read

Pharmacogenetics of Antiplatelets and Anticoagulants: A Report on Clopidogrel, Warfarin and DabigatranSemantic proximity Read

Effect of Gene Polymorphism on the Pharmacokinetics and Clinical Outcomes of Rivaroxaban: State-of-the-Art ReviewSemantic proximity Read

Genetic determinants of dabigatran plasma levels and their relation to bleeding.Semantic proximity Read

Gene polymorphism as a cause of hemorrhagic complications in patients with non-valvular atrial fibrillation treated with oral vitamin K-independent anticoagulants.Semantic proximity Read

The Distribution of the Genotypes of ABCB1 and CES1 Polymorphisms in Kazakhstani Patients with Atrial Fibrillation Treated with DOAC.Semantic proximity Read

Role of pharmacogenomics in the management of traditional and novel oral anticoagulants.Semantic proximity Read

The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese SubjectsSemantic proximity Read

Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran.Semantic proximity Read

Pharmacogenomic profiling of ABCB1 and CES1 in atrial fibrillation patients on dabigatran from a multiethnic Malaysian cohort.Semantic proximity Read

The Effect of ABCB1 and CES1 Polymorphisms on Plasma Levels of Dabigatran and Risk of Hemorrhagic Complications in Ischemic Stroke Patients.Semantic proximity Read